Overview

Staccato Loxapine Multidose PK

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The objectives of this trial are to assess the safety, tolerability, and pharmacokinetics of multiple inhaled doses of Staccato Loxapine.
Phase:
Phase 1
Details
Lead Sponsor:
Alexza Pharmaceuticals, Inc.
Collaborator:
Atlanta Center for Medical Research
Treatments:
Loxapine